adenosine has been researched along with Heart Failure in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (6.25) | 18.7374 |
1990's | 20 (17.86) | 18.2507 |
2000's | 36 (32.14) | 29.6817 |
2010's | 38 (33.93) | 24.3611 |
2020's | 11 (9.82) | 2.80 |
Authors | Studies |
---|---|
Bisignani, A; Crea, F; DE Vita, A; Denora, M; Filice, M; Golino, M; Ingrasciotta, G; Lamendola, P; Lanza, GA; Lanza, O; Manfredonia, L; Ravenna, SE; Ruscio, E; Villano, A | 1 |
Kruyt, ND; Nossent, AY; Quax, PHA; Woudenberg, T | 1 |
Devaux, Y; Dong, X; Jäger, C; Leszek, P; Linster, CL; Lumley, AI; Mączewski, M; Niedolistek, M; Oknińska, M; Paterek, A; Vausort, M | 1 |
Braun, T; Dieterich, C; Garcia-Gonzalez, C; Graumann, J; Kubin, T; Li, X; Maroli, G; Schneider, A; Stellos, K; Wiesnet, M; Wietelmann, A; Yuan, X | 1 |
Alfredsson, J; Ekenbäck, C; Erlinge, D; Hagström, H; Hambreus, K; Henareh, L; James, S; Omerovic, E; Redfors, B; Venetsanos, D | 1 |
Aurigemma, C; Bianchini, E; Burzotta, F; Ciliberti, G; Crea, F; D'Amario, D; Galli, M; Laborante, R; Leone, AM; Montone, RA; Princi, G; Restivo, A; Rodolico, D; Romagnoli, E; Trani, C; Vergallo, R; Zito, A | 1 |
Alcedo, KP; Battaglia, RA; Minor, M; Snider, NT | 1 |
Baine, S; Bonilla, IM; Carnes, CA; Fedorov, VV; Glynn, P; Györke, S; Hund, TJ; Kumar, S; Lee, NY; Long, VP; Mohler, PJ; Mowrey, K; Schober, K; Weiss, R | 1 |
Cheng, L; Eilbert, W | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Accornero, F; Dorn, LE; He, C; Hinger, SA; Janssen, PML; Wei, J; Whitson, BA | 1 |
Gao, X; Wu, Y; Xu, Y; Zhan, S | 1 |
Arnold, JR; Gulsin, GS; Khoo, J; Lai, FY; Levelt, E; McCann, GP; Shetye, A; Squire, IB; Swarbrick, DJ | 1 |
Alter, C; Borg, N; Ding, Z; Quast, C; Schrader, J | 1 |
Arnold, JR; Cheng, ASH; Kanagala, P; Marsh, AM; McAdam, J; McCann, GP; Ng, LL; Singh, A; Squire, IB | 1 |
Asanuma, H; Kitakaze, M | 1 |
Adatia, I; Atkins, DL; Checchia, PA; DeCaen, A; Fink, EL; Hazinski, MF; Hoffman, GM; Jefferies, JL; Kleinman, M; Krawczeski, CD; Laussen, PC; Licht, DJ; MacLaren, G; Macrae, D; Marino, BS; Ravishankar, C; Samson, RA; Tabbutt, S; Thiagarajan, RR; Toms, R; Tweddell, J | 1 |
Bonello, L; Cautella, J; Colomb, B; Cordier, C; Fenouillet, E; Gaubert, M; Guieu, R; Kerbaul, F; Kipson, N; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Resseguier, N; Ruf, J; Thuny, F | 1 |
Adamiak, M; Agarwal, N; Bouchareb, R; Chen, J; Chepurko, E; Fish, K; Hajjar, RJ; Ishikawa, K; Jha, D; Kohlbrenner, E; Lebeche, D; Liang, Y; Mathiyalagan, P; Mayourian, J; Sahoo, S; Sassi, Y; Singh, R; Trivieri, MG; Zhang, S | 1 |
Carreras, F; Díaz-Villanueva, J; Estofán, M; Gómez-Revelles, S; López-Lima, I; Pons-Lladó, G; Pujadas, S; Rossello, X; Sciarresi, E | 1 |
Baran, DA; Carter, KT; Cochran, RP; Copeland, H; Copeland, JG; Creswell, LL; Lirette, ST; Panos, AL | 1 |
Burzotta, F; Corvo, P; Cosentino, N; Crea, F; D'Amario, D; De Caterina, AR; De Vita, MR; Fabbiocchi, F; Ferrari, R; La Torre, G; Leone, AM; Lo Schiavo, P; Niccoli, G; Olivares, P; Porto, I; Rigattieri, S; Romagnoli, E; Tarantino, F; Tomai, F; Trani, C; Valgimigli, M | 1 |
Gupta, RC; Kohli, S; Lanfear, DE; Rastogi, S; Sabbah, HN; Wang, M; Zhang, K | 1 |
Camici, PG; Colombo, A; Durante, A; Latib, A; Pizzetti, G | 1 |
Biesiadecki, BJ; Billman, GE; Carnes, CA; Csepe, TA; Fedorenko, O; Fedorov, VV; Glukhov, AV; Györke, S; Hage, LT; Hansen, BJ; Kalyanasundaram, A; Li, N; Lou, Q; Mohler, PJ; Weiss, R | 1 |
Maggioni, AP | 1 |
Bryant, SM; Dudley, DJ; Halestrap, AP; James, AF; Khaliulin, I; Suleiman, MS | 1 |
Brennan, S; Hudman, D; Jackson, R; Lodwick, D; Norman, RI; Patel, M; Rainbow, RD; Sims, MW | 1 |
Fukushima, Y; Hakozaki, K; Hashimoto, H; Ishihara, K; Kiriyama, T; Kobayashi, Y; Kumita, S; Sakurai, M; Shimizu, W; Suda, M; Takahashi, N; Takano, H; Tomiyama, T | 1 |
Al-Kindi, SG; Benatti, RD; Deo, S; ElAmm, C; Ginwalla, M; Medalion, B; Oliveira, GH; Osman, MN; Park, SJ; Qattan, MY; Simon, DI | 1 |
Dilsizian, V; Gottdiener, J; Gottlieb, SS; Harris, KM; Kop, W; Krantz, DS; Li, S; Rodriguez, GA; Shankovich, A; Smith, MF; Wawrzyniak, AJ; Whittaker, KS | 1 |
Albrecht-Küpper, B; Dinh, W; Gheorghiade, M; Sabbah, HN; van der Laan, M; Voors, AA | 1 |
Asakura, M; Asanuma, H; Fujita, M; Funaya, H; Furukawa, H; Hori, M; Isomura, T; Kitakaze, M; Komamura, K; Nakamaru, K; Sanada, S; Sawa, Y; Taketani, S; Tsukamoto, O | 1 |
By, Y; Condo, J; Deharo, JC; Franceschi, F; Giorgi, R; Guieu, R; Ibrahim, Z; Monserrat, C; Saadjian, A | 1 |
Dubois, C | 1 |
Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M | 1 |
Davies, RA; Haddad, H; Mielniczuk, L; Reinglas, J | 1 |
Boccanelli, A; Brandimarte, C; Brandimarte, F; Cacciatore, G; Fedele, F; Gheorghiade, M; Mureddu, GF | 1 |
Devaux, Y; Wagner, DR | 1 |
Liang, S; Lin, H; Mo, A; Wen, Z; Zhang, F; Zhou, Y | 1 |
Hocher, B | 1 |
Bhatta, L; Ford, T; Kozman, H; Kshatriya, S; Liu, K; Michiel, R; Salah, A; Siddiqui, D; Villarreal, D | 1 |
Hullin, R; Keller, RF; Lerch, R; Meyer, P; White, M | 1 |
Floras, JS; Parmar, G; Rongen, GA; Wijeysundera, HC | 1 |
Bettari, L; Bugatti, S; Carubelli, V; Dei Cas, L; Lazzarini, V; Lombardi, C; Metra, M | 1 |
Arnaoutakis, GJ; Baumgartner, WA; Conte, JV; George, TJ; Shah, AS | 1 |
Andreotti, F; Buffon, A; Castriota, F; Cremonesi, A; Gurbel, PA; Kozinski, M; Kubica, A; Kubica, J; Musumeci, G; Navarese, EP; Tavazzi, L | 1 |
Arnaoutakis, GJ; Beaty, CA; Conte, JV; George, TJ; Halushka, MK; Shah, AS | 1 |
Gongadze, NV; Sukoyan, GV | 1 |
Niccoli, G; Sgueglia, GA; Tarantini, G | 1 |
Arora, R; Khosla, K; Khosla, S; Molnar, J; Shah, T; Singh, M; Singh, P | 1 |
Anderson, RD; Azarbal, B; Handberg, E; Johnson, BD; Kar, S; Kelsey, SF; Kothawade, K; Lerman, A; Mehta, PK; Merz, CN; Pepine, CJ; Petersen, J; Samuels, B; Sharaf, B; Shaw, L; Shufelt, C; Sopko, G; Wei, J | 1 |
Miller, JM; Williams, ES | 1 |
Ostrovskiĭ, IuP; Sidorenko, GI | 1 |
Chan, KY; Chiu, CW; Lam, WW; Sanderson, JE; So, NM | 1 |
Ali, S; Gouin, S | 1 |
Modlinger, PS; Welch, WJ | 1 |
DAL SANTO, G; GALEONE, A | 1 |
Birks, EJ; Johnson, PH; Kaletha, K; Kalsi, KK; Rybakowska, IM; Slominska, E; Smolenski, RT; Yacoub, MH; Yuen, AH | 1 |
Sharma, M; Teerlink, JR | 1 |
Tsubakihara, Y | 1 |
Abbracchio, MP; Camurri, A; Capecchi, PL; Diciolla, F; Laghi-Pasini, F; Lazzerini, PE; Maccherini, M; Mazzola, A; Pompella, G | 1 |
Alexander, RW; Gibbons, RJ; Kloner, RA; Ross, AM; Stone, GW | 1 |
Boscoe, M; Lango, R; Slominska, EM; Smolenski, RT; Suzuki, K; Yacoub, MH; Yuen, AH | 1 |
Berge-Lefranc, JL; Berland, Y; Carrega, L; Charavil, A; Dussol, B; Fenouillet, E; Gerolami, V; Giaime, P; Guieu, R; Mercier, L; Ruf, J; Saadjian, A | 1 |
Hindnavis, V; Tang, WH | 1 |
Chan, TO; Feldman, AM; Funakoshi, H; Good, JC; Herrmann, DE; Higuchi, Y; Jackson, EK; Koch, WJ; Lee, LL; Tang, Z; Zacharia, LC; Zhang, J | 1 |
Joseph, J; Rajaram, V | 1 |
Hisatome, I | 1 |
Asakura, M; Asanuma, H; Fujita, M; Furukawa, H; Isomura, T; Kim, J; Kitakaze, M; Komamura, K; Liao, Y; Nakamaru, K; Tomoike, H | 1 |
Khouadja, H; Mebazaa, A; Rezlan, E; Tavares, M; Vostroknoutova, I | 1 |
Greene, EL; Liang, KV; Redfield, MM; Williams, AW | 1 |
Miracle, C; Thomson, S; Vallon, V | 1 |
Böhm, M; De Luca, L; Dickstein, K; El-Banayosy, A; Filippatos, G; Gheorghiade, M; Mebazaa, A; Nieminen, M; Parissis, JT; Rhodes, A; Voors, AA; Zannad, F | 1 |
Chiu, J; Fonarow, GC; Hage, A; Hamilton, MA; Maclellan, WR; Middlekauff, HR; Moriguchi, J; Patel, J | 1 |
Bache, RJ; Chen, Y; Fassett, J; Hu, X; Li, Y; Lu, Z; Schnermann, J; Xu, X; Zhu, G | 1 |
Advenier, C | 1 |
James, T; Parmley, WW; Sievers, R; Wikman-Coffelt, J | 1 |
Frankis, MB; Grossman, SJ; Newman, WH; Webb, JG | 1 |
Forman, S; Heyrich, GP; Keen, WD; Marshall, ES; Raichlen, JS; Weitz, HH | 1 |
Goodfellow, J; Henderson, AH; Jones, CJ; Lewis, MJ; Luddington, LA; Ramsey, MW | 1 |
Mahmarian, AC; Mahmarian, JJ; Marks, GF; Pratt, CM; Verani, MS | 1 |
Cohn, JN; Francis, GS; McDonald, KM; Ugurbil, K; Yoshiyama, M; Zhang, J | 1 |
Albes, JM; Haverich, A; Rohde, R | 1 |
Bishop, SP; Komamura, K; Shannon, RP; Shen, YT; Vatner, SF | 1 |
Bakker, SJ; Leunissen, KM | 1 |
Marsh, JD; Vander Heide, RS | 1 |
Arnold, JE; Suarez, WA; Van Hare, GF; Wexler, ID | 1 |
Feldman, AM; McTiernan, C; Sanders, VJ; Wagner, DR | 1 |
Nekooeian, AA; Tabrizchi, R | 2 |
Canetti, M; Cohen, G; Elkayam, U; Karaalp, IS; Mehra, A; Tummala, PP; Wani, OR | 1 |
Castaño, HH; Dec, GW; Dinsmore, RE; Fifer, MA; Mathier, MA; Miyamoto, MI; Palacios, IF; Rose, GA; Semigran, MJ | 1 |
Brown, MD; Deveci, D; Hudlicka, O; Thomas, DP | 1 |
Feldman, AM; McNamara, DM; Wagner, DR | 1 |
Hori, M; Kitakaze, M | 2 |
Hashimoto, K; Inoue, K; Lurie, KG; Shirai, T; Sugiyama, A | 1 |
Edvinsson, L; Erlinge, D; Hedner, T; Sun, XY; Zhao, XH | 1 |
Gibbons, RJ; Hart, CY; Hodge, DO; Miller, TD | 1 |
Atchison, DJ; Floras, JS; Notarius, CF; Rongen, GA | 1 |
Gottlieb, SS | 1 |
Arimura, K; Egashira, K; Ide, T; Machida, Y; Nakamura, R; Shimokawa, H; Takeshita, A; Tsutsui, H | 1 |
Maehara, K; Maruyama, Y; Niitsuma, T; Oikawa, Y; Saito, T; Saitoh, S; Tamagawa, K | 1 |
Canty, JM; Fallavollita, JA | 1 |
Belloni, FL; Hintze, TH; Wang, J | 1 |
Bristow, MR; Feldman, AM; Hershberger, RE | 1 |
Burch, M; Carter, ND; Jeffery, S; Rigby, ML; Shinebourne, EA; Smith, A; Till, JA | 1 |
Apstein, CS; Cerel, AW; Vogel, WM | 1 |
Böhm, M; Diet, F; Erdmann, E; Kemkes, B; Wankerl, M | 1 |
Vatner, SF | 1 |
30 review(s) available for adenosine and Heart Failure
Article | Year |
---|---|
Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure.
Topics: Adenosine; Cytosine; Epigenesis, Genetic; Guanosine; Heart Failure; Humans; Inosine; Ribose; RNA, Small Untranslated; Transcriptome | 2022 |
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials.
Topics: Acute Coronary Syndrome; Adenosine; Atrioventricular Block; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Vasodilator Agents | 2023 |
Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Arteries; Calcinosis; Central Nervous System; Gene Expression Regulation; GPI-Linked Proteins; Heart Failure; Homeostasis; Humans; Mutation, Missense; Myocardial Infarction; Organ Specificity; Reperfusion Injury; Respiratory System | 2019 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
RNA modifications in cardiovascular diseases, the potential therapeutic targets.
Topics: Adenosine; Animals; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Epigenesis, Genetic; Fibrosis; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy; Metabolic Syndrome; Methylation; Mice; Microcirculation; Myocardium; Regeneration; Reperfusion Injury; RNA; RNA Processing, Post-Transcriptional; RNA, Untranslated; Transcriptome | 2021 |
Cardiopulmonary Resuscitation in Infants and Children With Cardiac Disease: A Scientific Statement From the American Heart Association.
Topics: Adenosine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Child; Guidelines as Topic; Heart Diseases; Heart Failure; Humans; Hypertension, Pulmonary; Vasodilator Agents | 2018 |
Partial Adenosine A1 Agonist in Heart Failure.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles | 2017 |
Cardiac protection during acute myocardial infarction.
Topics: Adenosine; Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Combined Modality Therapy; Heart Failure; Hospital Mortality; Humans; Myocardial Infarction; Purinergic P1 Receptor Agonists; Stents; Survival Rate; Thrombolytic Therapy | 2007 |
Cardiorenal syndrome and heart failure.
Topics: Adenosine; Anemia; Chronic Disease; Diuretics; Heart Failure; Hemofiltration; Humans; Kidney Failure, Chronic; Prognosis; Renin-Angiotensin System; Risk Factors; Vasodilator Agents; Vasopressins | 2010 |
Diuretic therapy in heart failure: current controversies and new approaches for fluid removal.
Topics: Adenosine; Cardiovascular Diseases; Heart Failure; Hemofiltration; Hormone Antagonists; Humans; Kidney Diseases; Risk Assessment; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Vasopressins; Water-Electrolyte Balance | 2010 |
Adenosine A1 receptor antagonists in clinical research and development.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Clinical Trials as Topic; Diuretics; Drug Resistance; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Receptor, Adenosine A1 | 2010 |
[What is new in the medical management of acute heart failure?].
Topics: Acute Disease; Adenosine; Algorithms; Cardiotonic Agents; Diuretics; Drug Therapy, Combination; Etiocholanolone; Heart Failure; Hemodiafiltration; Humans; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Prognosis; Relaxin; Risk Factors; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2010 |
Can we prevent or treat renal dysfunction in acute heart failure?
Topics: Acute Disease; Adenosine; Biomarkers; Cardiotonic Agents; Diuretics; Dopamine; Heart Failure; Humans; Kidney; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Prognosis; Vasodilator Agents; Vasopressins | 2012 |
Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials.
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Coronary Angiography; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Treatment Outcome | 2012 |
Ticagrelor in ST-elevation myocardial infarction.
Topics: Adenosine; Animals; Arrhythmias, Cardiac; Evidence-Based Medicine; Heart Failure; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2012 |
Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Creatine Kinase, MB Form; Electrocardiography; Heart Failure; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Randomized Controlled Trials as Topic; Stents; Stroke Volume; Vasodilator Agents | 2012 |
[The no-reflow phenomenon and its clinical significance].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Atherectomy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Heart Failure; Hospital Mortality; Humans; Microvascular Angina; Myocardial Infarction; Nicorandil; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Stents; Vasodilator Agents; Verapamil | 2002 |
Adenosine A1 receptor antagonists and the kidney.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Heart Failure; Humans; Kidney; Receptor, Adenosine A1; Renal Insufficiency; Reperfusion Injury | 2003 |
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
[Hemodialysis-related hypotension].
Topics: Adenosine; Antihypertensive Agents; Arteriosclerosis; Autonomic Nervous System Diseases; Body Weight; Heart Failure; Humans; Hypotension; Hypotension, Orthostatic; Kidney Failure, Chronic; Nitric Oxide; Renal Dialysis | 2004 |
Current and novel pharmacological approaches to renal insufficiency in heart failure.
Topics: Adenosine; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Agents; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Natriuretic Agents; Natriuretic Peptide, Brain; Natriuretic Peptides; Neurotransmitter Agents; Prognosis; Renal Insufficiency; Treatment Outcome; Vasodilator Agents; Vasopressins | 2006 |
Role of adenosine antagonism in the cardio-renal syndrome: pathophysiology and therapeutic potential.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Diuresis; Heart Failure; Humans; Prognosis; Renal Circulation; Renal Insufficiency; Vasodilator Agents | 2007 |
New pharmacologic therapies for acute heart failure.
Topics: Acute Disease; Adenosine; Adenosine Triphosphatases; Antidiuretic Hormone Receptor Antagonists; Cardiac Myosins; Cardiotonic Agents; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Natriuretic Peptides; Pyridazines; Simendan | 2008 |
Acute decompensated heart failure and the cardiorenal syndrome.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Dopamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Renal Insufficiency; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Ultrafiltration; Vasopressins | 2008 |
Adenosine and kidney function: potential implications in patients with heart failure.
Topics: Adenosine; Animals; Heart Failure; Humans; Kidney; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Receptors, Purinergic P1; Reperfusion Injury; Vasoconstriction; Vasopressins; Xanthines | 2008 |
Overview of emerging pharmacologic agents for acute heart failure syndromes.
Topics: Adenosine; Cardiovascular Agents; Endothelin-1; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Hydrazones; Natriuretic Peptide, Brain; Perhexiline; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Sodium-Potassium-Exchanging ATPase; Syndrome; Vasodilator Agents | 2008 |
[Theophylline: mechanism of action, pharmacokinetics and metabolism].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adult; Calcium; Child; Cyclic AMP; Drug Interactions; Heart Failure; Humans; Kinetics; Liver Diseases; Muscle Contraction; Muscle, Smooth; Phosphodiesterase Inhibitors; Respiration Disorders; Theophylline | 1981 |
It is time to ask what adenosine can do for cardioprotection.
Topics: 5'-Nucleotidase; Adenosine; Cardiovascular Agents; Collateral Circulation; Heart Failure; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion Injury; Protein Kinase C | 1998 |
Adenosine therapy: a new approach to chronic heart failure.
Topics: Adenosine; Animals; Cardiac Output, Low; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1 | 2000 |
Renal effects of adenosine A1-receptor antagonists in congestive heart failure.
Topics: Adenosine; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Prognosis; Purinergic P1 Receptor Antagonists; Sodium | 2001 |
8 trial(s) available for adenosine and Heart Failure
Article | Year |
---|---|
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.
Topics: Adenosine; Heart Failure; Humans; Prospective Studies; Registries; Stroke Volume; Takotsubo Cardiomyopathy; Treatment Outcome; Ventricular Function, Left | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: t
Topics: Adenosine; Aged; Coronary Angiography; Coronary Circulation; Drug Administration Schedule; Electrocardiography; Female; Heart Failure; Hospitalization; Humans; Italy; Male; Microcirculation; Middle Aged; Myocardial Infarction; Nitroprusside; Percutaneous Coronary Intervention; Recurrence; Suction; Thrombectomy; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents | 2013 |
Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failure.
Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Brachial Artery; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Norepinephrine; Reflex; Regional Blood Flow; Sympathetic Nervous System; Tetrazoles; Vasodilator Agents | 2011 |
Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Antihypertensive Agents; Atherectomy, Coronary; Atrial Fibrillation; Azithromycin; Chlamydophila Infections; Coronary Disease; Defibrillators, Implantable; Double-Blind Method; Eplerenone; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Myocardial Reperfusion; Pyridines; Radiology, Interventional; Spironolactone; Stents; Thiazepines; Thrombolytic Therapy | 2002 |
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
Topics: Adenosine; Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Thrombolytic Therapy; Vasodilator Agents | 2005 |
Cyclooxygenase products sensitize muscle mechanoreceptors in humans with heart failure.
Topics: Adenosine; Adult; Aminophylline; Blood Pressure; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Hand Strength; Heart Failure; Heart Rate; Humans; Indomethacin; Infusions, Intravenous; Male; Mechanoreceptors; Mechanotransduction, Cellular; Middle Aged; Muscle Contraction; Muscle, Skeletal; Peroneal Nerve; Prostaglandin-Endoperoxide Synthases; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Reflex; Research Design; Sympathetic Nervous System; Time Factors | 2008 |
Effect of adenosine receptor blockade with caffeine on sympathetic response to handgrip exercise in heart failure.
Topics: Adenosine; Blood Pressure; Caffeine; Exercise Test; Female; Hand Strength; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Ischemia; Isometric Contraction; Isotonic Contraction; Male; Middle Aged; Muscle, Skeletal; Purinergic P1 Receptor Antagonists; Reflex; Sympathetic Nervous System | 2001 |
75 other study(ies) available for adenosine and Heart Failure
Article | Year |
---|---|
Coronary microvascular dysfunction and findings of heart failure with preserved ejection fraction in patients with microvascular angina.
Topics: Adenosine; Heart Failure; Humans; Myocardial Ischemia; Stroke Volume | 2022 |
Regulation of N6-Methyladenosine after Myocardial Infarction.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Female; Heart Failure; Humans; Myocardial Infarction; RNA, Messenger; Ventricular Function, Left | 2022 |
ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
Topics: Adenosine; Adenosine Deaminase; Animals; Heart Failure; Inosine; Interferon Regulatory Factor-7; Interferon-Induced Helicase, IFIH1; Interferons; Mice; Mice, Mutant Strains; NF-kappa B; RNA | 2022 |
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Bee Venoms; Biological Clocks; Chronic Disease; Dogs; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart Failure; Heart Rate; In Vitro Techniques; Male; Patch-Clamp Techniques; Potassium Channel Blockers; Receptor, Adenosine A1; Sinoatrial Node; Xanthines | 2020 |
High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 2020 |
Remodeling of the m
Topics: Adenosine; Animals; Animals, Newborn; Base Sequence; Biocatalysis; Cardiomegaly; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Rats; RNA, Messenger; Stress, Physiological; Transcription, Genetic | 2021 |
Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
Topics: Adenosine; Aged; Aged, 80 and over; Cardiomyopathies; Contrast Media; Coronary Angiography; Diagnosis, Differential; Female; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Risk Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Aorta; Collagen; Constriction; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation; Interleukin-3; Male; Mice; Mice, Knockout; Signal Transduction; T-Lymphocytes | 2017 |
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Cause of Death; Clinical Trials as Topic; Contrast Media; Coronary Circulation; Echocardiography; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Prognosis; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2018 |
Cutting Edge Science and Medicine of Adenosine in Patients With Heart Failure.
Topics: Adenosine; Dilatation; Heart Diseases; Heart Failure; Humans; Ventricular Dysfunction, Left | 2018 |
Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock.
Topics: Adenosine; Aged; Blood Pressure; Female; Heart Failure; Humans; Male; Myocardial Contraction; Myocardial Infarction; Prospective Studies; Receptor, Adenosine A2A; Shock, Cardiogenic; Vasodilation | 2018 |
FTO-Dependent N
Topics: Adenosine; Adult; Aged; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Calcium Signaling; Case-Control Studies; Cell Line; Cell Proliferation; Demethylation; Disease Models, Animal; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Myocardial Infarction; Myocytes, Cardiac; Rats, Sprague-Dawley; Regeneration; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Sus scrofa; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Prognostic value of a new semiquantitative score system for adenosine stress myocardial perfusion by CMR.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Arrhythmias, Cardiac; Coronary Artery Disease; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis | 2019 |
The Effect of Cardiac Preservation Solutions on Heart Transplant Survival.
Topics: Adenosine; Adolescent; Adult; Aged; Allografts; Allopurinol; Cardioplegic Solutions; Disaccharides; Electrolytes; Female; Follow-Up Studies; Glucose; Glutamates; Glutathione; Graft Rejection; Graft Survival; Heart; Heart Failure; Heart Transplantation; Histidine; Humans; Insulin; Male; Mannitol; Middle Aged; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Retrospective Studies; Saline Solution; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Acute intravenous infusion of an adenosine regulating agent improves left ventricular function in dogs with advanced heart failure.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Deoxyribonucleosides; Dogs; Heart Failure; Hemodynamics; Infusions, Intravenous; Purinergic P1 Receptor Antagonists; Theophylline; Ventricular Function, Left | 2013 |
[A high-volume single center experience of no-reflow post-percutaneous coronary intervention].
Topics: Adenosine; Aged; Female; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Nitroprusside; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Retrospective Studies; Ventricular Function, Left | 2014 |
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artificial; Dogs; Dose-Response Relationship, Drug; Fibrosis; Heart Conduction System; Heart Failure; Receptor, Adenosine A1; Sinoatrial Node; Tachycardia; Theophylline; Up-Regulation; Voltage-Sensitive Dye Imaging; Xanthines | 2014 |
[Multination clinical trials: what is the relevance and what are the lessons from across-country differences?].
Topics: Acute Coronary Syndrome; Adenosine; Americas; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Ethnicity; Europe; Female; Georgia (Republic); Heart Failure; Humans; Internationality; Male; Metoprolol; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Russia; Sample Size; Spironolactone; Ticagrelor; Ticlopidine; Tolvaptan | 2014 |
Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion.
Topics: Adenosine; Animals; Glycogen; Heart Failure; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Myocardium; Rats; Rats, Wistar; Reperfusion Injury | 2014 |
Early opening of sarcolemmal ATP-sensitive potassium channels is not a key step in PKC-mediated cardioprotection.
Topics: Action Potentials; Adenosine; Animals; Cardiotonic Agents; Cell Separation; Diazoxide; Enzyme Activation; Heart Failure; Ion Channel Gating; Ischemic Preconditioning, Myocardial; Isoenzymes; KATP Channels; Male; Myocardial Contraction; Myocardial Reperfusion; Myocytes, Cardiac; Phenotype; Pinacidil; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Rats, Wistar; Sarcolemma; Tetradecanoylphorbol Acetate; Time Factors | 2015 |
Patients with reduced heart rate response to adenosine infusion have low myocardial flow reserve in (13)N-ammonia PET studies.
Topics: Adenosine; Aged; Ammonia; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Female; Fractional Flow Reserve, Myocardial; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2015 |
Platelet inhibition with ticagrelor for left ventricular assist device thrombosis.
Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Heart Failure; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Thrombosis; Ticagrelor; Treatment Outcome; Ventricular Function, Left | 2015 |
High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates.
Topics: Adenosine; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Agents; Coronary Circulation; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Stress, Psychological; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2015 |
Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure.
Topics: 5'-Nucleotidase; Adenosine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Female; Gene Expression; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Severity of Illness Index; Stroke Volume | 2008 |
Peripheral plasma adenosine release in patients with chronic heart failure.
Topics: Adenosine; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Coronary Sinus; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Serum Albumin; Troponin I | 2009 |
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Failure; Heart Neoplasms; Heart Rate; Humans; Hypotension; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Retrospective Studies; Rhabdomyoma; Shock, Cardiogenic; Tachycardia, Supraventricular; Thyrotropin; Treatment Outcome | 2010 |
Playing hide and seek with adenosine receptors.
Topics: Adenosine; Animals; Heart Failure; Heart Function Tests; Humans; Mice; Mice, Transgenic; Receptors, Purinergic P1 | 2008 |
Continuous perfusion of donor hearts with oxygenated blood cardioplegia improves graft function.
Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Cardiac Output; Glutathione; Heart Arrest, Induced; Heart Failure; Heart Transplantation; Insulin; Ischemia; Male; Malondialdehyde; Organ Preservation; Organ Preservation Solutions; Perfusion; Raffinose; Swine; Swine, Miniature; Time Factors | 2010 |
The cardiorenal syndrome in heart failure: an evolving paradigm.
Topics: Adenosine; Heart Failure; Humans; Kidney Diseases; Natriuretic Agents; Ultrafiltration; Vasopressins | 2010 |
Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation.
Topics: Adenosine; Adult; Allopurinol; Cohort Studies; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Heart Failure; Heart Transplantation; Histidine; Humans; Insulin; Kaplan-Meier Estimate; Male; Mannitol; Middle Aged; Multivariate Analysis; Organ Preservation; Organ Preservation Solutions; Raffinose; Retrospective Studies; Survival Rate; Treatment Outcome; United States | 2011 |
Effectiveness of nuclear scan strategy in low-risk chest pain patients: novel insights from the real world.
Topics: Adenosine; Angina, Unstable; Chest Pain; Coronary Artery Disease; Coronary Stenosis; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Prognosis; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2011 |
A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allograft biopsy specimens.
Topics: Adenosine; Adult; Allopurinol; Biopsy; Disaccharides; Electrolytes; Female; Glutamates; Glutathione; Graft Rejection; Heart Failure; Heart Transplantation; Histidine; Humans; Incidence; Insulin; Male; Mannitol; Middle Aged; Multivariate Analysis; Myocardial Reperfusion Injury; Myocardium; Necrosis; Organ Preservation; Organ Preservation Solutions; Primary Graft Dysfunction; Raffinose; Retrospective Studies; Survival Rate; Transplantation, Homologous | 2012 |
Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency.
Topics: Acetyldigoxins; Adenosine; Adenosine Triphosphate; Animals; Apoptosis; Cardiotonic Agents; Constriction, Pathologic; Female; Heart; Heart Failure; Heart Ventricles; Hydrazones; Male; Milrinone; Myocardium; Myocytes, Cardiac; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridazines; Rabbits; Reperfusion; Simendan; Ventricular Function | 2011 |
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Topics: Acetylcholine; Adenosine; Adult; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Coronary Vessels; Female; Heart Failure; Hospitalization; Humans; Laser-Doppler Flowmetry; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Nitroglycerin; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Stroke; United States; Vasodilator Agents | 2012 |
Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Electrocardiography; Feasibility Studies; Female; Gadolinium DTPA; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Troponin T | 2003 |
A patient with chaotic atrial tachycardia.
Topics: Abnormalities, Multiple; Adenosine; Anti-Asthmatic Agents; Asthma; Bronchiolitis; Combined Modality Therapy; Diagnosis, Differential; Dyspnea; Electroencephalography; Emergencies; Female; Fluid Therapy; Furosemide; Heart Failure; Heart Septal Defects, Atrial; Humans; Infant; Procainamide; Recurrence; Tachycardia; Tachycardia, Ectopic Atrial | 2003 |
[Adenosine-tri-phosphatase activity of the heart in myocardial insufficiency].
Topics: Adenosine; Heart Failure; Humans; Myocardium; Phosphoric Monoester Hydrolases | 1952 |
Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Topics: Adenosine; Adult; AMP Deaminase; Bacterial Proteins; Exercise Test; Female; Heart Failure; Heterozygote; Homozygote; Humans; Male; Mutation; Myocardium; N-Acetylmuramoyl-L-alanine Amidase; Polymorphism, Single-Stranded Conformational; Protein Isoforms | 2003 |
Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation.
Topics: Adenosine; Blotting, Western; Female; Heart Failure; Humans; Lipopolysaccharides; Male; Middle Aged; Neutrophils; Phenethylamines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; Triazines; Triazoles; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
Prevention of adriamycin induced heart failure by an increase in endogenous adenosine production.
Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Doxorubicin; Echocardiography; Heart Failure; Nucleotides; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; Chromatography; Creatinine; Cross-Sectional Studies; Female; Freeze Drying; Gene Expression; Heart Failure; Humans; Inflammation; Kidney Failure, Chronic; Leukocytes, Mononuclear; Male; Middle Aged; Prognosis; Receptor, Adenosine A2A; Renal Dialysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2007 |
A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Disease Models, Animal; Female; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Myocardium; Receptor, Adenosine A1; Receptor, Adenosine A2A; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation; Ventricular Dysfunction, Left | 2007 |
Adenosine and cardioprotection in chronic heart failure: genes and protein expression.
Topics: Adenosine; Adult; Aged; Chronic Disease; Female; Gene Expression; Heart Failure; Humans; Male; Middle Aged; Myocardium; Receptors, Purinergic P1 | 2007 |
Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure.
Topics: Adenosine; Adult; Aged; Chronic Disease; Dipyridamole; Female; Gene Expression; Gene Expression Profiling; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oligonucleotide Array Sequence Analysis; Phosphodiesterase Inhibitors; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
Topics: 5'-Nucleotidase; Adenosine; Animals; Blood Pressure; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Fibrosis; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases; Ventricular Dysfunction, Left | 2008 |
Energy levels at systole vs. diastole in normal hamster hearts vs. myopathic hamster hearts.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cricetinae; Energy Metabolism; Heart Failure; Lactates; Lactic Acid; Mesocricetus; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphates; Phosphocreatine; Systole | 1983 |
Increased myocardial adenosine release in heart failure.
Topics: Adenosine; Animals; Dogs; Heart Failure; Heart Ventricles; Isoproterenol; Myocardial Contraction; Myocardium | 1984 |
Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular surgery.
Topics: Adenosine; Aged; Aged, 80 and over; Chi-Square Distribution; Female; Heart; Heart Failure; Humans; Intraoperative Complications; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Peripheral Vascular Diseases; Postoperative Complications; Predictive Value of Tests; Preoperative Care; Pulmonary Edema; Radionuclide Imaging; Regression Analysis; Risk Factors; Sensitivity and Specificity; Vasodilator Agents | 1995 |
Endothelial control of arterial distensibility is impaired in chronic heart failure.
Topics: Acetylcholine; Adenosine; Blood Flow Velocity; Brachial Artery; Cardiomyopathy, Dilated; Case-Control Studies; Female; Heart Failure; Humans; Iliac Artery; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Ultrasonography; Vascular Resistance; Vasodilation; Vasodilator Agents | 1995 |
Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Death, Sudden, Cardiac; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed | 1995 |
Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction.
Topics: Adenosine; Adenosine Triphosphate; Animals; Coronary Circulation; Dogs; Heart Failure; Hypertrophy, Left Ventricular; Magnetic Resonance Spectroscopy; Myocardial Infarction; Myocardium; Phosphocreatine; Time Factors; Ventricular Function, Left | 1994 |
Protection of the right ventricular myocardium during acute right heart failure from pulmonary hypertension.
Topics: Acute Disease; Adenosine; Allopurinol; Animals; Cardioplegic Solutions; Disease Models, Animal; Embolectomy; Evaluation Studies as Topic; Extracorporeal Circulation; Glucose; Glutathione; Heart Arrest, Induced; Heart Failure; Hypertension, Pulmonary; Insulin; Male; Myocardial Reperfusion Injury; Organ Preservation Solutions; Pulmonary Embolism; Raffinose; Rats; Rats, Inbred Lew; Tromethamine; Ventricular Function, Right | 1994 |
Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure.
Topics: Adenosine; Animals; Blood Pressure; Blood Vessels; Cardiac Pacing, Artificial; Coronary Circulation; Diastole; Dogs; Endocardium; Female; Heart Failure; Hemodynamics; Male; Microcirculation; Reference Values; Ventricular Function, Left | 1993 |
Hypothesis on cellular ATP depletion and adenosine release as causes of heart failure and vasodilatation in cardiovascular beriberi.
Topics: Acetyl Coenzyme A; Acidosis, Lactic; Adenosine; Adenosine Triphosphate; Beriberi; Ethanol; Heart Failure; Humans; Ketoglutarate Dehydrogenase Complex; Models, Biological; Pyruvate Dehydrogenase Complex Deficiency Disease; Thiamine; Vasodilation | 1995 |
Through the looking glass: a positive inotropic drug and ischemic preconditioning.
Topics: 5'-Nucleotidase; Adenosine; Animals; Cardiotonic Agents; Dogs; Drug Approval; Enzyme Activation; Heart Failure; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardium; Neutropenia; Protein Kinase C; Pyrazines; Quinolines; Second Messenger Systems | 1997 |
Atrial flutter: an uncommon pediatric manifestation of hyperthyroidism.
Topics: Adenosine; Atrial Flutter; Child, Preschool; Electrocardiography; Heart Failure; Humans; Hyperthyroidism | 1997 |
Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart.
Topics: Adenosine; Adult; Analysis of Variance; Cardiovascular Agents; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Heart Failure; Humans; In Vitro Techniques; Lipopolysaccharides; Male; Middle Aged; Tubercidin; Tumor Necrosis Factor-alpha | 1998 |
Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Topics: Acute Disease; Adenosine; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Male; Microspheres; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Vascular Resistance; Ventricular Function, Left | 1998 |
Renal circulatory effects of adenosine in patients with chronic heart failure.
Topics: Adenosine; Adult; Blood Flow Velocity; Chronic Disease; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Renal Circulation; Vascular Resistance; Ventricular Dysfunction, Left | 1998 |
Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.
Topics: Acetylcholine; Acute Disease; Adenosine; Adolescent; Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Coronary Circulation; Endothelium, Vascular; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Stroke Volume; Systole; Vasodilator Agents; Ventricular Function, Left | 1998 |
Alterations in small arterioles precede changes in limb skeletal muscle after myocardial infarction.
Topics: Acetylcholine; Adenosine; Animals; Arterioles; Female; Heart Failure; Hemodynamics; Muscle, Skeletal; Myocardial Infarction; Norepinephrine; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Ventricular Function, Left | 1998 |
Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Topics: Adenosine; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiac Output; Coronary Disease; Heart Failure; Heart Rate; Hemodynamics; Ligation; Male; Organ Size; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Time Factors; Vascular Resistance | 1998 |
AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
Topics: Adenosine; Adenosine Monophosphate; Alleles; AMP Deaminase; Cardiomyopathy, Dilated; Disease Progression; Energy Metabolism; Genetic Predisposition to Disease; Genotype; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1 | 1999 |
Measurement of adenylate cyclase activity in the right ventricular endomyocardial biopsy samples from patients with chronic congestive heart failure.
Topics: Adenosine; Adenylyl Cyclases; Adult; Biopsy; Cell Membrane; Chronic Disease; Colforsin; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Norepinephrine; Spectrometry, Fluorescence | 2000 |
Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats.
Topics: Adenosine; Adenosine Triphosphate; Animals; Blood Pressure; Cardiovascular System; Decerebrate State; Down-Regulation; Electric Stimulation; Ganglia; Heart Failure; Heart Rate; Male; Myocardial Infarction; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2 | 2000 |
Specificity of the stress electrocardiogram during adenosine myocardial perfusion imaging in patients taking digoxin.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiotonic Agents; Coronary Disease; Diagnosis, Differential; Digoxin; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Radionuclide Ventriculography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Vasodilator Agents | 2000 |
Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Adenosine; Animals; Coronary Circulation; Dogs; Echocardiography; Endothelium, Vascular; Enzyme Inhibitors; Heart Failure; Hyperemia; Immunohistochemistry; Indicators and Reagents; Lipid Peroxidation; Myocardium; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pacemaker, Artificial; Reactive Oxygen Species; Tachycardia; Vasodilator Agents | 2001 |
Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure.
Topics: Acetylcholine; Adenosine; Animals; Carbon Dioxide; Coronary Circulation; Diastole; Dogs; Endothelium, Vascular; Fasting; Female; Heart Failure; Heart Rate; Hemodynamics; Male; Nitric Oxide; Nitroarginine; Oxygen; Partial Pressure; Perfusion; Regional Blood Flow | 2002 |
Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium.
Topics: Adenosine; Animals; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Heart; Heart Failure; Hemodynamics; Myocardial Ischemia; Perfusion; Reference Values; Swine; Systole; Time Factors; Vasoconstriction; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |
Adenosine causes bradycardia in pacing-induced cardiac failure.
Topics: Adenosine; Animals; Cardiac Pacing, Artificial; Cardiomegaly; Depression, Chemical; Dogs; Heart; Heart Failure; Heart Rate; Parasympathetic Nervous System; Pressoreceptors; Sinoatrial Node | 1992 |
A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adult; Female; GTP-Binding Proteins; Heart Failure; Humans; In Vitro Techniques; Male; Myocardium; Phenylisopropyladenosine; Receptors, Purinergic; Vasodilator Agents | 1991 |
Plasma concentration of atrial natriuretic peptide in spontaneous atrioventricular re-entrant tachycardias of childhood.
Topics: Adenosine; Age Factors; Atrial Natriuretic Factor; Child, Preschool; Heart Failure; Heart Rate; Humans; Infant; Infant, Newborn; Tachycardia, Atrioventricular Nodal Reentry | 1990 |
Post-ischemic cardiac chamber stiffness and coronary vasomotion: the role of edema and effects of dextran.
Topics: Adenosine; Animals; Blood Pressure; Coronary Disease; Dextrans; Edema, Cardiac; Elasticity; Heart Failure; Hypoxia; In Vitro Techniques; Osmotic Pressure; Perfusion; Rabbits; Vascular Resistance; Vasodilation | 1986 |
Inotropic response to DPI 201-106 in the failing human heart.
Topics: Adenosine; Adult; Aged; Aging; Calcium; Carbachol; Electric Stimulation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Papillary Muscles; Piperazines; Receptors, Adrenergic, beta | 1989 |
Reduced subendocardial myocardial perfusion as one mechanism for congestive heart failure.
Topics: Adenosine; Animals; Cardiomegaly; Coronary Circulation; Dogs; Endocardium; Heart Failure; Heart Rate; Hyperemia; Pericardium; Physical Exertion; Vascular Resistance | 1988 |